Halt Rosiglitazone (Avandia) Trial
Links shared publicly online about this topic.
- 1,023total visits
Halt Rosiglitazone (Avandia) Trial
View full resource at citizen.org
Tags: Diabetes Type 2 Medication, Diabetes Medication, FDA, Avandia, Avandamet, Avandaryl
Most Recently Shared on July 14, 2010 at 2:23 pm By:
#Avandia - Dr Sidney Wolfe (Public Citizen) addresses OPH. PC's letter to FDA here: http://bit.ly/cBqWx3. Wolfe not a big Rosi fan.
WCIR: Rosiglitazone Not Linked to Heart Hazard in BARI 2D (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “LOS ANGELES (MedPage Today) -- After further data review, the insulin-sensitizing agent rosiglitazone (Avandia) appears to have reduced rates of cardiovascular events in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, researchers said here.” View full resource at qualitypointtech.net
Most Recently Shared on November 8, 2010 at 6:49 pm By:
WCIR: Rosiglitazone Not Linked to Heart Hazard in BARI 2D (CME/CE): LOS ANGELES (MedPage Today) -- After further d... http://bit.ly/dblQgf
FDA Says Rosiglitazone Can Stay, But EMA Pulls the Plug - QualityPoint Technologies
qualitypointtech.net — “After months of deliberations, the FDA has opted to allow GlaxoSmithKline to continue to market Avandia for the treatment of type 2 diabetes, despite its much ballyhooed cardiovascular risk profile. It also opted to stop the TIDE trial, pending a rereview of the RECORD trial. But in sharp contrast, the EMA has ordered the withdrawal of all rosiglitazone-containing products. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on September 23, 2010 at 6:36 pm By:
FDA Says Rosiglitazone Can Stay, But EMA Pulls the Plug: After months of deliberations, the FDA has opted to allow... http://bit.ly/chvu9Q
FDA Orders Halt on Avandia Trial Enrollment :: Diabetes Self-Management
diabetesselfmanagement.com — “The US Food and Drug Administration has ordered GlaxoSmithKline (GSK), maker of the controversial diabetes drug Avandia, to halt enrollment in the TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) trial, designed to compare the cardiovascular safety of Avandia to that of the diabetes drug Actos in people with Type 2...” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 23, 2010 at 7:51 pm By:
#diabetes The FDA has ordered a halt on enrollment in the Avandia TIDE trial. http://bit.ly/cUTTxL
Statement On FDA Placing Hold On TIDE Safety Trial
medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) informed GlaxoSmithKline (GSK), the manufacturer of rosiglitazone (Avandia), that the postmarketing safety trial known as TIDE has been placed on partia” View full resource at medicalnewstoday.com
Most Recently Shared on July 23, 2010 at 3:17 pm By:
Statement On FDA Placing Hold On Avandia TIDE Safety Trial http://bit.ly/aWToZ9
Statement on FDA Placing Hold on TIDE Safety Trial
endo-society.org — “The U.S. Food and Drug Administration (FDA) today informed GlaxoSmithKline (GSK), the manufacturer of rosiglitazone (Avandia), that the postmarketing safety trial known as TIDE has been placed on partial clinical hold...” View full resource at endo-society.org
Most Recently Shared on July 23, 2010 at 1:04 pm By:
Statement on FDA Placing Hold on TIDE Safety Trial http://tinyurl.com/28pxacp
PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial
pharmagossip.blogspot.com — “PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial” View full resource at pharmagossip.blogspot.com
Most Recently Shared on July 23, 2010 at 7:24 am By:
PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial: The European Medicines ... http://bit.ly/cZ2Srx
PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial - Jack's posterous
pharmagossip.posterous.com — “PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on July 23, 2010 at 7:24 am By:
PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial http://post.ly/oOlY
A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial - Health Blog - WSJ
blogs.wsj.com — “Also: surpluses at nonprofit insurers; tainted heparin investigation; new rules on external review of denied insurance claims.” View full resource at blogs.wsj.com
Most Recently Shared on July 22, 2010 at 12:52 pm By:
A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial http://on.wsj.com/clYxWT
Avandia maker ordered to halt recruiting for trials - The Boston Globe
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on July 22, 2010 at 6:43 am By:
Avandia maker ordered to halt recruiting for trials - The Boston Globe http://retwt.me/1NXKb (via @prasadgurjar555)
FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - White Coat Notes - Boston.com
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on July 22, 2010 at 1:14 am By:
FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - .. http://retwt.me/1NXAA (via @BostonMedJobs)
FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - White Coat Notes - Boston.com
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on July 22, 2010 at 12:59 am By:
FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - Wh.. http://retwt.me/1NXzX (via @GlobeHealth)
FDA halts new enrollment in Glaxo's Avandia trial http://link.reuters.com/fap78m
reuters.com — “FDA halts new enrollment in Glaxo's Avandia trial http://link.reuters.com/fap78m” View full resource at reuters.com
Most Recently Shared on July 21, 2010 at 5:21 pm By:
FDA halts new enrollment in Glaxo's Avandia trial http://link.reuters.com/fap78m
FDA will consider halting TIDE, based on advisory committee's input
theheart.org — “Responding to a report issued by the Senate Finance Committee, FDA commissioner Margaret Hamburg says the agency is convening a joint advisory committee meeting to get expert opinion on all the recent evidence questioning rosiglitazone's cardiovascular safety profileif need be, the agency could stop the much-debated TIDE trial.” View full resource at theheart.org
Most Recently Shared on July 14, 2010 at 1:20 pm By:
#Avandia IoM's Steve Goodman and Ruth Faden present their take on ethics of a trial like TIDE, something FDA asked for. http://bit.ly/cE7Pp3
Reanalysis of rosiglitazone meta-analysis raises questions
theheart.org — “A new analysis of the same 42 trials, but using a number of different statistical methods to account for all the zero events, found no significant increase in either MI or CV death and highlights flaws in the original study. In response, Nissen counters that the report is now neither useful nor relevant in the wake of the FDA hearing. The FDA panel chair says the whole saga highlights the need for drug-approval reform. (Diamond G et al. Ann Intern Med; published online before print August 6, 200” View full resource at theheart.org
Most Recently Shared on July 13, 2010 at 10:19 pm By:
#Avandia - Last minute question Kaul to Nissen! Recall Kaul co-authored rosiglitazone critique of Nissen's 2007 paper: http://bit.ly/dwD8yi
Advertisement

